2012
DOI: 10.1292/jvms.11-0507
|View full text |Cite
|
Sign up to set email alerts
|

Transglutaminase 2: A Novel Autoantigen in Canine Idiopathic Central Nervous System Inflammatory Diseases

Abstract: ABSTRACT. Necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE) and granulomatous meningoencephalomyelitis (GME) are common idiopathic inflammatory central nervous system (CNS) diseases with unknown etiology in dogs. We previously showed that IgG autoantibodies in the cerebrospinal fluid (CSF) of NME cases reacted to unknown brain proteins as well as to glial fibrillary acidic protein (GFAP). In the present report, we evaluated the autoantibodies against transglutaminase2 (TG2) in the cani… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 28 publications
(53 reference statements)
0
2
0
Order By: Relevance
“…The addition of recombinant canine TG2 antigen to the samples before testing them in the ELISA is required to exclude non‐specific effects. However, the measurement of canine anti‐TG2 antibodies has previously been performed in the cerebrospinal fluid of dogs presenting with inflammatory meningoencephalitis in which verification of the ELISA was performed successfully . Measurement in the serum has not previously been undertaken.…”
Section: Discussionmentioning
confidence: 99%
“…The addition of recombinant canine TG2 antigen to the samples before testing them in the ELISA is required to exclude non‐specific effects. However, the measurement of canine anti‐TG2 antibodies has previously been performed in the cerebrospinal fluid of dogs presenting with inflammatory meningoencephalitis in which verification of the ELISA was performed successfully . Measurement in the serum has not previously been undertaken.…”
Section: Discussionmentioning
confidence: 99%
“…In veterinary medicine, disease-specific markers and their potential prognostic value have not yet been validated. Auto-antibodies against astrocytes such as anti-glial fibrillary acidic protein (GFAP) (142, 143) and anti-transglutaminase-2 (TG-2) antibodies (144) have been identified in dogs with MUE and particularly NME. Nonetheless, there is currently no evidence available linking the presence of these biomarkers to canine ON and its outcome.…”
Section: Discussionmentioning
confidence: 99%